A new study found that people with systemic lupus erythematosus (SLE) may face a significantly higher risk of developing ...
A new study finds anifrolumab (Saphnelo) may reduce harmful inflammation and improve signs of overall immune health.
Researchers investigated belimumab's (Benlysta®) effect on low platelet (thrombocytopenia) and low white blood cell ...
The House Appropriations Committee has approved the Fiscal Year 2027 Defense Appropriations bill, which includes $10 million ...
This July, we're shining a light on one of the most meaningful ways the lupus community can drive treatment forward: participating in lupus research. Follow along as we explore what participation ...
Lupus Canada awarded the 2026 Lupus Canada Catalyst Grant to Andrea Knight, MD, MSCE, Associate Professor, Division of Rheumatology and Associate Scientist, Neurosciences and Mental Health, The ...
The Lupus Foundation of America (LFA) is proud to announce Reeve Bright as the top fundraiser of the LFA’s inaugural Men on a Mission™ campaign.
Join the Lupus Foundation of America for our 2026 National Summer Support Event — a casual summer-themed virtual gathering ...
Lupus can cause joint pain (arthralgia) and inflammation in and around the joints, resulting in problems like arthritis, tendonitis, and carpal tunnel syndrome. Joint problems related to lupus usually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results